The association between colorectal cancer and prior antibiotic prescriptions: case control study

[1]  H. Tilg,et al.  The Intestinal Microbiota in Colorectal Cancer. , 2018, Cancer cell.

[2]  H. Amoli,et al.  Role of gut microbiota in the pathogenesis of colorectal cancer , 2018 .

[3]  T. Smieszek,et al.  Antibiotics in primary care in England: which antibiotics are prescribed and for which conditions? , 2018, The Journal of antimicrobial chemotherapy.

[4]  H. Pommergaard,et al.  Linking Gut Microbiota to Colorectal Cancer , 2017, Journal of Cancer.

[5]  David A. Drew,et al.  Long-term use of antibiotics and risk of colorectal adenoma , 2017, Gut.

[6]  E. Giovannucci,et al.  Meat intake and risk of diverticulitis among men , 2017, Gut.

[7]  H. Qin,et al.  Gut microbiota and colorectal cancer , 2017, European Journal of Clinical Microbiology & Infectious Diseases.

[8]  B. Rachet,et al.  Do colorectal cancer patients diagnosed as an emergency differ from non-emergency patients in their consultation patterns and symptoms? A longitudinal data-linkage study in England , 2016, British Journal of Cancer.

[9]  Mayuko Yamamoto,et al.  Gut microbiota and colorectal cancer , 2016, Genes and Environment.

[10]  Simon de Lusignan,et al.  Royal College of General Practitioners Research and Surveillance Centre (RCGP RSC) sentinel network: a cohort profile , 2016, BMJ Open.

[11]  F. Ryan,et al.  Tumour-associated and non-tumour-associated microbiota in colorectal cancer , 2016, Gut.

[12]  H. Glatt,et al.  Modified Ames test using a strain expressing human sulfotransferase 1C2 to assess the mutagenicity of methyleugenol , 2016, Genes and Environment.

[13]  M. V. van Oijen,et al.  Frequent Use of Antibiotics Is Associated with Colorectal Cancer Risk: Results of a Nested Case–Control Study , 2015, Digestive Diseases and Sciences.

[14]  P. Larsen,et al.  Specific and non-specific symptoms of colorectal cancer and contact to general practice. , 2015, Family practice.

[15]  Yu-Xiao Yang,et al.  Impact of antibiotic exposure on the risk of colorectal cancer , 2015, Pharmacoepidemiology and drug safety.

[16]  Z. Tulassay,et al.  Colorectal Cancer in Patients with Inflammatory Bowel Disease: The True Impact of the Risk , 2014, Digestive Diseases.

[17]  N. Tözün,et al.  Diet, microbiota, and colorectal cancer. , 2014, Journal of clinical gastroenterology.

[18]  Harry J. Flint,et al.  The gut microbiota, bacterial metabolites and colorectal cancer , 2014, Nature Reviews Microbiology.

[19]  T. Keku,et al.  Gut Microbiome and Colorectal Adenomas , 2014, Cancer journal.

[20]  Richard A. Moore,et al.  Co-occurrence of anaerobic bacteria in colorectal carcinomas , 2013, Microbiome.

[21]  J. Ravel,et al.  Microbiome, demystifying the role of microbial communities in the biosphere , 2013, Microbiome.

[22]  M. Gulliford,et al.  Validity of cancer diagnosis in a primary care database compared with linked cancer registrations in England. Population-based cohort study. , 2012, Cancer epidemiology.

[23]  Bas E Dutilh,et al.  A bacterial driver–passenger model for colorectal cancer: beyond the usual suspects , 2012, Nature Reviews Microbiology.

[24]  Liping Zhao,et al.  Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers , 2011, The ISME Journal.

[25]  A. Aromaa,et al.  Antibiotic use predicts an increased risk of cancer , 2008, International journal of cancer.

[26]  Sander Greenland,et al.  Multiple comparisons and association selection in general epidemiology. , 2008, International journal of epidemiology.

[27]  E. Holmes,et al.  Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. , 2008, Environmental microbiology.

[28]  J. Jansson,et al.  Clindamycin-induced enrichment and long-term persistence of resistant Bacteroides spp. and resistance genes. , 2006, The Journal of antimicrobial chemotherapy.

[29]  S. Selvachandran,et al.  Symptomatic presentation of early colorectal cancer. , 2006, Annals of the Royal College of Surgeons of England.

[30]  J. Doré,et al.  Resilience of the Dominant Human Fecal Microbiota upon Short-Course Antibiotic Challenge , 2005, Journal of Clinical Microbiology.

[31]  K J Rothman,et al.  No Adjustments Are Needed for Multiple Comparisons , 1990, Epidemiology.

[32]  J. Perman.  Methane and colorectal cancer , 1984 .

[33]  Simon de Lusignan,et al.  Uptake of a Dashboard Designed to Give Realtime Feedback to a Sentinel Network About Key Data Required for Influenza Vaccine Effectiveness Studies , 2018, MIE.

[34]  M. Alebouyeh,et al.  Role of gut microbiota in the pathogenesis of colorectal cancer; a review article , 2018, Gastroenterology and hepatology from bed to bench.

[35]  C. Mcnulty,et al.  English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) 2010 to 2014: report 2015 , 2015 .

[36]  Malcolm Puntis,et al.  Skills for Communicating with Patients (2nd edn) , 2006 .